Potential Limitations of Bioluminescent Xenograft Mouse Models: A Systematic Review.

CONCLUSIONS: In general, BLI remains a valid tool for pre-clinical assessment of tumor burden. While no single factor may be identified as a general limitation, data should be interpreted with caution.
PMID: 32407285 [PubMed - as supplied by publisher]

Source: J Pharm Pharm Sci - May 15, 2020 Category: Drugs & Pharmacology Authors: Shen YT, Asthana R, Peeters C, Allen C, DeAngelis C, Piquette-Miller M Tags: J Pharm Pharm Sci Source Type: research